Vertex Pharmaceuticals (VRTX) Cash from Operations (2009 - 2026)

Vertex Pharmaceuticals' Cash from Operations history runs 18 years deep, the most recent figure standing at 1428100000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 74.39% year-over-year to 1428100000.0; the TTM figure through Mar 2026 stood at 4240600000.0 (up 532.58% YoY), while the FY2025 annual figure was 3631400000.0, up 837.19% from the prior year.
• Cash from Operations was 1428100000.0 for Q1 2026 at Vertex Pharmaceuticals, up from 498000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 1428100000.0 in Q1 2026 to a low of 3753600000.0 in Q2 2024.
• Historically, Cash from Operations has averaged 719652941.18 across 5 years, with a median of 1073100000.0 in 2025.
• The sharpest annual moves came in 2022 and 2024: Cash from Operations soared 670.76% in 2022, then sank 430.89% in 2024.
• A 5-year view of Cash from Operations shows it stood at 1078400000.0 in 2022, then slumped by 78.25% to 234600000.0 in 2023, then jumped by 149.19% to 584600000.0 in 2024, then decreased by 14.81% to 498000000.0 in 2025, then soared by 186.77% to 1428100000.0 in 2026.
• The last three Cash from Operations figures came in at 1428100000.0 (Q1 2026), 498000000.0 (Q4 2025), and 1241400000.0 (Q3 2025), per Business Quant data.